Ultrasound guided fine needle aspiration cytology (FNAC) of unclear lesions in melanoma patients

被引:3
作者
Voit, C
Mayer, T
Proebstle, T
Schwürzer-Voit, M
Kron, M
Weber, L
Sterry, W
Schoengen, A
机构
[1] Humboldt Univ, Universitatshautklin, Charite, D-10117 Berlin, Germany
[2] Bundeswerhrkrankenhaus Ulm, Innere Med Abt, Ulm, Germany
[3] Johannes Gutenberg Univ Mainz, Haut Klin, Mainz, Germany
[4] Univ Ulm, Abt Biometrie & Stat, Ulm, Germany
[5] Univ Ulm, Abt Dermatol, Ulm, Germany
来源
ULTRASCHALL IN DER MEDIZIN | 2000年 / 21卷 / 05期
关键词
melanoma; ultrasound; fine needle aspiration cytology (FNAC); ultrasound-guided FNAC;
D O I
10.1055/s-2000-7986
中图分类号
O42 [声学];
学科分类号
070206 ; 082403 ;
摘要
Aim: Fine needle aspiration cytology (FNAC) is widely used in oncology to obtain the diagnosis of unclear tumours in cancer patients. However, because the method is established only in few melanoma centers, we performed this study to evaluate ultrasound guided FNAC in routine follow-up of melanoma patients. Method: Unclear tumours recognised during routine follow-up of melanoma patients underwent ultrasound guided fine needle aspiration with cytological examination. The results were then compared to subsequent histopathology or future clinical outcome. Results: 275 unclear tumours received ultrasound guided fine needle aspiration with cytological examination. Sensitivity showed to be 95.6% [95% Cl: 91.5 - 98.1], specificity was 100% [95% CI: 96.2 - 100.0], The positive predictive value was 100,0% [95% Cl: 97.9 - 100.0], the negative predictive Value 92,2% [95% Cl: 85.1 % - 96.9%]. In 89 cases lesions turned out to be cytologically benign thus diagnosis avoiding surgery. In lesions with diameters up to 10mm sensitivity and specificity were 91.4% and 100.0%, respectively. Conclusion: Ultrasound guided FNAC proved to be a minimal invasive procedure in the diagnosis of unclear tumours in the follow-up of melanoma patients. It allows definite diagnosis and avoids unnecessary diagnostic surgery.
引用
收藏
页码:218 / 222
页数:5
相关论文
共 31 条
[21]   The impact of ultrasound scanning in the staging and follow-up of patients with clinical stage I cutaneous melanoma [J].
Rossi, CR ;
Seno, A ;
Vecchiato, A ;
Foletto, M ;
Tregnaghi, A ;
DeCandia, A ;
Rubaltelli, L ;
Montesco, C ;
Lise, M .
EUROPEAN JOURNAL OF CANCER, 1997, 33 (02) :200-203
[22]  
SCHOENGEN A, 1993, HAUTARZT, V44, P703
[23]  
SCHOENGEN A, 1994, ONKOLOGIE, V17, P420
[24]   Identification of lymph node metastases by use of polymerase chain reaction (PCR) in melanoma patients [J].
SchwurzerVoit, M ;
Proebstle, TM ;
Sterry, W .
EUROPEAN JOURNAL OF CANCER, 1996, 32A (02) :264-268
[25]  
Stadelmann WK, 1998, Cutaneous Melanoma, P11
[26]  
Ulrich J, 1999, ULTRASCHALL MED, V20, P197
[27]   DIFFERENTIATION OF BENIGN FROM MALIGNANT SUPERFICIAL LYMPHADENOPATHY - THE ROLE OF HIGH-RESOLUTION US [J].
VASSALLO, P ;
WERNECKE, K ;
ROOS, N ;
PETERS, PE .
RADIOLOGY, 1992, 183 (01) :215-220
[28]   Identification of melanoma metastases by tyrosinase reverse transcription polymerase chain reaction of fine needle aspirates [J].
Voit, C ;
Schoengen, A ;
Weber, L ;
Proebstle, T .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1998, 39 (06) :1030-1032
[29]   Detection of regional melanoma metastases by ultrasound B-scan, cytology or tyrosinase RT-PCR of fine-needle aspirates [J].
Voit, C ;
Schoengen, A ;
Schwürzer, M ;
Weber, L ;
Mayer, T ;
Proebstle, TM .
BRITISH JOURNAL OF CANCER, 1999, 80 (10) :1672-1677
[30]  
Voit C, 2000, CANCER CYTOPATHOL, V90, P186, DOI 10.1002/1097-0142(20000625)90:3<186::AID-CNCR7>3.3.CO